Activity Details

Free CME
1.0 AMA PRA Category 1 Credit(s)
Released: December 18, 2019
Expires: December 17, 2020
60 minutes to complete

Accredited By

This continuing medical education activity is provided by

Target Audience

The intended audience for this activity is pulmonologists, rheumatologists, and other health care professionals involved in the management of patients with progressive fibrosing interstitial lung disease (PF-ILD).

Learning Objectives

Upon successful completion of the activity, participants should be better able to:
  • Apply the latest evidence and guidelines to identity patients with PF-ILD in a timely and accurate manner.
  • Assess the latest clinical evidence in the management of PF-ILD, including the significance of both pulmonary and non-pulmonary endpoints.
  • Identify patients with worsening PF-ILD despite receiving current standard of care who may benefit from emerging treatment options.
  • Review the importance of a multidisciplinary approach for the improved diagnosis and treatment of patients with PF-ILD.

Activity Description

Interstitial lung disease (ILD) describes a group of more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, occupational hazards, or an underlying medical condition, such as connective tissue disease (CTD). Patients with systemic sclerosis, rheumatoid arthritis, or poly-/dermato-myositis have the greatest risk of developing CTD-associated ILD. Idiopathic pulmonary fibrosis (IPF) is the most common ILD, although patients who develop a progressive fibrosing (PF) phenotype are subject to similar outcomes. With historically limited treatment options, pulmonologists, rheumatologists, and other providers who care for patients with PF-ILD are unaware of how new options and data for patients with IPF may benefit those suffering from PF-ILD. In this continuing medical education activity featuring the Wheel of Knowledge, expert physicians discuss the latest information regarding the diagnosis and treatment of PF-ILD.


Activity Chair:
Fernando J. Martinez, MD, MS
Division of Pulmonary and Critical Care Medicine
Weill Cornell Medicine
New York, NY
  • Disclosures:
  • Consulting Fee: AstraZeneca, Boehringer Ingelheim, Bridge Biotherapeutics, Chiesi, Gala, Genentech, GlaxoSmithKline, ProterixBio, Sunovion
  • Speakers Bureau Details: Boehringer Ingelheim
  • Contracted Research: Afferent/Merck, AstraZeneca, Biogen, Boehringer Ingelheim, GlaxoSmithKline, Nitto Avecia Pharma Services, Patara/Respivant, Promedior, Prometic, Veracyte
  • Data Safety & Monitoring Board: Biogen, Boehringer Ingelheim, Genentech, GlaxoSmithKline

Kevin R. Flaherty, MD, MS
Professor of Medicine
Division of Pulmonary/Critical Care Medicine
Director, Michigan Medicine Interstitial Lung Disease Clinic
University of Michigan
Ann Arbor, MI
  • Disclosures:
  • Consulting Fee: Bellerophon Therapeutics, Boehringer Ingelheim, Roche/Genentech, Veracyte
  • Contracted Research: Boehringer Ingelheim, Roche/Genentech

Lisa H. Lancaster, MD
Associate Professor
Division of Allergy, Pulmonary, and Critical Care Medicine
Director, Vanderbilt Interstitial Lung Disease Program
Vanderbilt University Medical Center
Nashville, TN
  • Disclosures:
  • Salary (spouse): Medtronic
  • Consulting Fee: Bellerophon, Boehringer Ingelheim, Bristol-Myers Squibb, Galapagos, Genentech, Veracyte
  • Speakers Bureau: Boehringer Ingelheim, Genentech
  • Contracted Research: Biogen, Boehringer Ingelheim, Celgene, Galapagos, Novartis, Veracyte

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
  • Disclosure: No relevant financial relationships to disclose.
Vindico Medical Education Staff:
  • Disclosure: No relevant financial relationships to disclose.

Signed Disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Conflict of Interest Policy/Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the CME content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

MIPS Qualifying Activity
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.

To meet the criteria for improvement activities in the MIPS of the Quality Payment Program (QPP), accredited CME providers need to implement activities that:

  • address a quality or safety gap that is supported by a needs assessment or problem analysis or support the completion of such a needs assessment as part of the activity;
  • have specific, measurable aim(s) for improvement;
  • include interventions intended to result in improvement;
  • include data collection and analysis of performance data to assess the impact of the interventions; and
  • define meaningful clinician participation in their activity, describe the mechanism for identifying clinicians who meet the requirements, and provide participant completion information.

Statement of Commercial Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.


The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.